Rx · PZN 19279507, 19477549, 20575435, 19665937
WEZENLA 130 mg concentrate for preparation of a solution for infusion
German trade nameWEZENLA 130 mg Konzentrat zur Herstellung einer Infusionslösung
Consistently available
9.6out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
WEZENLA 130 mg concentrate for preparation of a solution for infusion is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsWEZENLA 130 mg concentrate for preparation of a solution for infusion contains the active ingredient Ustekinumab and comes as Concentrate for solution for infusion. 4 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available.
Pack sizes · 4 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 19279507 | 9.4 | 9.6 | ~ €2,351 |
| 19477549 | 0.0 | 0.0 | ~ €2,349 |
| 20575435 | 0.0 | 0.0 | ~ €2,349 |
| 19665937 | 0.0 | 0.0 | ~ €2,350 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch